NGF – Pioneering Preventive Neuromedicine & Neurotheranostics

NGF's is developing a brain-organoid platform to revolutionize drug screening and personalized neuromedicine. Founding team is a group of experienced bio scientists collaborating  with Singapore government agency A-Stars  to pioneer preventive neuromedicine and neurotheranostics.  Scheduled to list on Canadia TSX in Feb and planning to go US Nasdaq at appropriate time soon.